Kevin J. McNamara

CIK: 0001207137

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (46.7%)

Position reduction

Option Exercises (M)7 (23.3%)

Derivative conversions

Awards (A)5 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (13.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CHE

CHEMED CORP

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (30 total)

CHE
CHEMED CORP
Oct 20, 2026
Award(A)
Stock Option (right to buy with tandem tax withholding)
Direct
36.7K shares at avg. $512.64-
CHE
CHEMED CORP
Sep 18, 2026
Sale(S)
Direct
2K shares at avg. $501.40$1.0M
CHE
CHEMED CORP
Aug 21, 2026
Sale(S)
Direct
2K shares at avg. $541.16$1.1M
CHE
CHEMED CORP
Aug 3, 2026
Exercise(M)
Stock Option (right to buy with tandem tax withholding)
Direct
2K shares at avg. $445.35-
CHE
CHEMED CORP
Aug 3, 2026
Sale(S)
Direct
2K shares at avg. $539.51$1.1M
CHE
CHEMED CORP
Jul 31, 2026
Exercise(M)
Direct
2K shares at avg. $445.35$891K
CHE
CHEMED CORP
Jul 31, 2026
Tax Payment(F)
Direct
19.8K shares at avg. $529.22$10.5M
CHE
CHEMED CORP
May 1, 2026
Sale(S)
Direct
2K shares at avg. $421.13$842K
CHE
CHEMED CORP
Mar 27, 2026
Sale(S)
Direct
1.5K shares at avg. $369.37$554K
CHE
CHEMED CORP
Mar 12, 2026
Sale(S)
Direct
2K shares at avg. $403.18$806K
CHE
CHEMED CORP
Feb 13, 2026
Exercise(M)
Direct
2.7K shares at avg. $469.56$1.3M
CHE
CHEMED CORP
Feb 13, 2026
Award(A)
Performance Stock Units
Direct
5.1K shares-
CHE
CHEMED CORP
Feb 13, 2026
Tax Payment(F)
Direct
1.2K shares at avg. $469.56$560K
CHE
CHEMED CORP
Feb 13, 2026
Exercise(M)
Direct
0 shares at avg. $469.56-
CHE
CHEMED CORP
Nov 24, 2025
Sale(S)
Direct
2K shares at avg. $437.55$875K
CHE
CHEMED CORP
Oct 21, 2025
Award(A)
Stock Option (right to buy with tandem tax withholding)
Direct
58.7K shares at avg. $443.79-
CHE
CHEMED CORP
Sep 26, 2025
Sale(S)
Direct
3K shares at avg. $461.28$1.4M
CHE
CHEMED CORP
Aug 5, 2025
Sale(S)
Direct
2K shares at avg. $428.55$857K
CHE
CHEMED CORP
May 5, 2025
Exercise(M)
Direct
10K shares at avg. $471.74$4.7M
CHE
CHEMED CORP
May 5, 2025
Tax Payment(F)
Direct
9K shares at avg. $574.02$5.2M
CHE
CHEMED CORP
May 5, 2025
Sale(S)
Direct
1.5K shares at avg. $576.45$865K
CHE
CHEMED CORP
Mar 31, 2025
Sale(S)
Direct
1K shares at avg. $615.33$615K
CHE
CHEMED CORP
Mar 6, 2025
Sale(S)
Direct
2K shares at avg. $593.67$1.2M
CHE
CHEMED CORP
Feb 14, 2025
Exercise(M)
Direct
1.2K shares at avg. $553.39$683K
CHE
CHEMED CORP
Feb 14, 2025
Exercise(M)
Direct
4.1K shares at avg. $553.39$2.3M

		Type	Shares	Price		Ownership
Oct 20, 2026	CHE CHEMED CORP	Award(A) Stock Option (right to buy with tandem tax withholding)	36,693	$512.64	-	Direct
Sep 18, 2026	CHE CHEMED CORP	Sale(S)	2,000	$501.40	$1,002,800	Direct
Aug 21, 2026	CHE CHEMED CORP	Sale(S)	2,000	$541.16	$1,082,320	Direct
Aug 3, 2026	CHE CHEMED CORP	Exercise(M) Stock Option (right to buy with tandem tax withholding)	2,001	$445.35	-	Direct
Aug 3, 2026	CHE CHEMED CORP	Sale(S)	2,000	$539.51	$1,079,020	Direct
Jul 31, 2026	CHE CHEMED CORP	Exercise(M)	2,001	$445.35	$891,145	Direct
Jul 31, 2026	CHE CHEMED CORP	Tax Payment(F)	19,802	$529.22	$10,479,614	Direct
May 1, 2026	CHE CHEMED CORP	Sale(S)	2,000	$421.13	$842,260	Direct
Mar 27, 2026	CHE CHEMED CORP	Sale(S)	1,500	$369.37	$554,055	Direct
Mar 12, 2026	CHE CHEMED CORP	Sale(S)	2,000	$403.18	$806,360	Direct
Feb 13, 2026	CHE CHEMED CORP	Exercise(M)	2,714	$469.56	$1,274,386	Direct
Feb 13, 2026	CHE CHEMED CORP	Award(A) Performance Stock Units	5,114	-	-	Direct
Feb 13, 2026	CHE CHEMED CORP	Tax Payment(F)	1,192	$469.56	$559,716	Direct
Feb 13, 2026	CHE CHEMED CORP	Exercise(M)	0	$469.56	$0	Direct
Nov 24, 2025	CHE CHEMED CORP	Sale(S)	2,000	$437.55	$875,100	Direct
Oct 21, 2025	CHE CHEMED CORP	Award(A) Stock Option (right to buy with tandem tax withholding)	58,672	$443.79	-	Direct
Sep 26, 2025	CHE CHEMED CORP	Sale(S)	3,000	$461.28	$1,383,840	Direct
Aug 5, 2025	CHE CHEMED CORP	Sale(S)	2,000	$428.55	$857,100	Direct
May 5, 2025	CHE CHEMED CORP	Exercise(M)	10,000	$471.74	$4,717,400	Direct
May 5, 2025	CHE CHEMED CORP	Tax Payment(F)	8,982	$574.02	$5,155,848	Direct
May 5, 2025	CHE CHEMED CORP	Sale(S)	1,500	$576.45	$864,675	Direct
Mar 31, 2025	CHE CHEMED CORP	Sale(S)	1,000	$615.33	$615,330	Direct
Mar 6, 2025	CHE CHEMED CORP	Sale(S)	2,000	$593.67	$1,187,340	Direct
Feb 14, 2025	CHE CHEMED CORP	Exercise(M)	1,235	$553.39	$683,437	Direct
Feb 14, 2025	CHE CHEMED CORP	Exercise(M)	4,086	$553.39	$2,261,152	Direct

1-25 of 30 transactions

About MCNAMARA KEVIN J

MCNAMARA KEVIN J (SEC CIK 0001207137) files insider reports with the SEC as president and CEO of CHEMED CORP (CHE).

Signal8 holds 19 ownership filings by MCNAMARA KEVIN J, all Form 4s, filed between Sep 27, 2024 and Oct 22, 2026. Those filings report 30 transactions, from Sep 26, 2024 to Oct 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MCNAMARA KEVIN J's filings is in CINCINNATI, OH.

Recent filings by MCNAMARA KEVIN J

Oct 20, 2026: Grant or award of CHE derivative securities (Form 4, code A).
Sep 18, 2026: Open-market sale of CHE shares (Form 4, code S).
Aug 21, 2026: Open-market sale of CHE shares (Form 4, code S).
Aug 3, 2026: Option exercise of CHE derivative securities (Form 4, code M).
Aug 3, 2026: Open-market sale of CHE shares (Form 4, code S).

Other insiders filing for CHEMED CORP (CHE)

LEE SPENCER S, executive vice president
Wherley Joel L, CEO - Vitas Healthcare
Judkins Brian C, VP and Chief Legal Officer
HUTTON THOMAS C, vice president
Witzeman Michael D, VP & Chief Financial Officer
GRACE PATRICK P, Director

How to read Form 4 transaction codes